Communique from the Annual General Meeting of Scandion Oncology A/S
On May 29th, 2019, the Annual General Meeting of Scandion Oncology A/S (”Scandion Oncology” or the“Company”) was held. Below follows a summary of the established decisions. All decisions were taken with the required majority.The Board of Directors report on the Company’s business in the past year The general meeting took note of the Board of Directors report on the Company’s activities in 2018. Presentation of the audited annual report for 2018 for approval The general meeting unanimously adopted the audited annual report for 2018. Decision to transfer the deficit for next year